A detailed history of Rogco, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Rogco, LP holds 12 shares of LLY stock, worth $9,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$9,060
Previous $10.9 Million 2.15%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $4,201 - $4,953
-8 Reduced 40.0%
12 $7 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $8,694 - $11,986
20 New
20 $10.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rogco, LP Portfolio

Follow Rogco, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.